semaglutide effect on metabolism Frontiers A Review of the Oral

LEADER has the advantage of longer follow-up data

Patients should actively communicate changes in their medication regimen and consult their healthcare provider before making any adjustments

Note that similar medications like Ozempic (semaglutide) and Mounjaro (tirzepatide) are FDA-approved only for diabetes management, not weight loss

Today, GLP-1 drugs, including Wegovy, Mounjaro and Zepbound, have become household names and key tools in the fight against obesity: 1 in 8 American adults say they have used a GLP-1 drug, and forecasts show that by 2030, 1 in 10 Americans will likely be using these medications

Novo Nordisk, the manufacturer of Wegovy, also provides a tool that allows you to check your insurance coverage

Research shows that 67.8% of patients experience at least a 5% decrease in body weight within just a few months of starting treatment